Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC ProgramBusiness Wire • 05/06/26
Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery TechnologiesPRNewsWire • 04/16/26
Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second PhasePRNewsWire • 04/15/26
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate ProgramBusiness Wire • 04/14/26
Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Next-Generation Tumor-Activated ADCsBusiness Wire • 03/17/26
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.Business Wire • 03/05/26
SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery TechnologyBusiness Wire • 02/23/26
BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal AnalyticsBusiness Wire • 02/17/26
DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi SankyoBusiness Wire • 02/04/26
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center EuropeBusiness Wire • 01/22/26
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in OncologyPRNewsWire • 01/21/26
Daiichi Sankyo Company, Limited (DSNKY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo® in France, Denmark, Iceland, Sweden, Finland and NorwayBusiness Wire • 01/08/26
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern EuropeBusiness Wire • 01/07/26
Daiichi Sankyo Company, Limited (DSNKY) Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day TranscriptSeeking Alpha • 12/16/25
Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology ResearchPRNewsWire • 12/15/25